Prazol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prazol

Property Description
Active ingredient Lansoprazole (C16H14F3N3O2S)
Form Oral delayed-release capsules, tablets
Pharmacological class Proton Pump Inhibitor (PPI)
General purpose Sustained reduction of gastric acid output
Origin Synthetic, Substituted benzimidazole

Prazol is the trade name for a medicine containing the active substance Lansoprazole, a potent Proton Pump Inhibitor (PPI). The medication is defined by its ability to provide strong and sustained control over the body's acid production. Lansoprazole is a synthetic compound, chemically derived from the substituted benzimidazole structure.


What Type of Medicine is Prazol?

Prazol is a prescription-only antisecretory agent clinically recognized for its reliable classification as a Proton Pump Inhibitor (PPI). This classification signifies that the drug is designed to achieve a powerful reduction in the volume of acid produced by the stomach lining, operating differently than simple antacids that only neutralize existing acid. Its primary therapeutic goal is the fundamental suppression of gastric acid output, making it highly effective for managing conditions linked to excessive acidity. Lansoprazole acts to decrease the amount of acid made in the stomach, providing relief for scenarios like frequent heartburn.


Prazol's Primary Action and General Purpose

The general purpose of Prazol is to facilitate the healing of irritated or damaged tissues by creating a low-acid environment in the stomach and esophagus. It achieves this by directly and irreversibly targeting the Proton Pump (H^+/K^+-ATPase), which is the enzyme responsible for pumping acid into the stomach. This mechanism ensures prolonged relief and aids in protecting the sensitive lining of the upper digestive tract from corrosive damage. Proton Pump Inhibitors, including Lansoprazole, lead to the strong inhibition of gastric acid secretion.


Composition and Available Forms of Lansoprazole

Lansoprazole is provided as a single-ingredient product, primarily in oral dosage forms like delayed-release capsules or disintegrating tablets. It may also be available as an intravenous solution for administration in specific clinical settings. As the active ingredient is highly sensitive to stomach acid, the oral preparations utilize specialized pharmaceutical excipients to create an enteric-coated system. This coating is a critical design feature, distinguishing it from non-protected formulations and ensuring the drug bypasses the harsh stomach environment for optimal absorption and therapeutic effect.

What side effects are possible with Prazol?

Possible Side Effects and Safety Information

The information regarding the adverse effects and safety constraints for Prazol (Lansoprazole) is based strictly on governmental regulatory documents, including the FDA Prescribing Information and the EMA Summary of Product Characteristics (SmPC). This content details the risks documented in official labeling.


Documented Adverse Reactions and Frequency

Adverse effects are categorized by frequency based on regulatory standards (e.g., Common: 1/100 to <1/10).

Frequency Classification Common Adverse Reactions (SOC)
Common Headache, Dizziness, Diarrhea, Abdominal Pain, Nausea, Constipation, Rash, Fatigue
Uncommon Depression, Joint Pain (Arthralgia), Muscle Pain (Myalgia), Bone Fracture (Hip, Wrist, Spine)
Rare/Very Rare Severe skin reactions (SJS/TEN), Anaphylactic Shock, Thrombocytopenia (low platelets), Interstitial Nephritis, Jaundice
Not Known Low Magnesium (Hypomagnesemia), Vitamin B12 Deficiency, Clostridium difficile-associated diarrhea (CDAD), Fundic Gland Polyps

Serious Safety Warnings and Constraints

Regulatory labeling specifies several serious or clinically significant warnings:

  • Bone Fracture Risk: Long-term use (typically over one year) and high doses may be associated with an increased risk of osteoporosis-related fractures of the hip, wrist, or spine.
  • Severe Skin Reactions: The medicine has been associated with rare but life-threatening conditions such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).
  • Long-Term Exposure Concerns: Prolonged use (e.g., exceeding one year) is associated with risks of Hypomagnesemia and the development of Fundic Gland Polyps. Use exceeding three years is associated with Vitamin B12 deficiency.
  • Specific Populations: Use is not recommended in children under one year of age. Caution is required in patients with hepatic (liver) impairment, and dose restriction may be necessary.
  • Malignancy Preclusion: Symptomatic response to treatment does not preclude the presence of a gastric malignancy; this condition must be considered in follow-up.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Prazol (Lansoprazole) defines the necessary response to overdosage based on mandated emergency actions and specified supportive management.

Overdose Scope Official Regulatory Statement
Documented Manifestations No clinically significant adverse reactions were observed following single oral doses up to 600 mg in healthy subjects. Acute symptoms are not explicitly listed in regulatory documents.
Emergency Action Required Get medical help or contact a Poison Control Center right away.

Management and Official Requirements

The regulatory basis confirms the necessity of seeking urgent medical attention in any case of suspected overdosage. The official classification states that treatment must be symptomatic and supportive.

Supportive Measures Regulatory Status
Specific Antidote A specific antidote is not available for Lansoprazole.
Drug Removal Lansoprazole cannot be removed from circulation by haemodialysis.

Despite studies reporting a low risk of acute toxicity, official instructions mandate that individuals must seek immediate medical assistance for any suspected overdose. The regulatory documentation focuses on these required actions and management constraints, as specialized monitoring requirements or population-specific considerations are not explicitly defined in the acute overdose section. The official guidance permits the potential use of activated charcoal and gastric emptying as general supportive measures.

Therapeutic Uses of Prazol

What Prazol treats: main uses and benefits

Prazol is a medication classified as a proton pump inhibitor (PPI). Its primary function is to reduce the production of gastric acid by targeting the enzyme system in the stomach lining responsible for acid secretion. This reduction in acidity allows the digestive tract to heal and prevents further irritation of the mucosal lining.

Treatment of Acid-Related Conditions

Prazol is commonly used to manage several conditions where excess stomach acid leads to discomfort or tissue damage:

  • Gastroesophageal Reflux Disease (GERD): It helps alleviate symptoms such as heartburn and acid regurgitation by preventing stomach acid from rising into the esophagus.
  • Erosive Esophagitis: For patients with inflammation or sores in the esophagus caused by chronic acid exposure, the medication facilitates the healing of the esophageal tissue.
  • Gastric and Duodenal Ulcers: Prazol is used to treat active ulcers in the stomach or the upper part of the small intestine, providing an environment that supports the repair of the gastric mucosa.
  • Zollinger-Ellison Syndrome: This medication is used to manage rare pathological hypersecretory conditions where the stomach produces extreme amounts of acid.

Eradication of Helicobacter pylori

In cases where peptic ulcers are associated with Helicobacter pylori infection, Prazol is used as part of a combination regimen. By suppressing acid, it enhances the effectiveness of co-administered antibiotics, helping to eliminate the bacteria and reduce the risk of ulcer recurrence.

Benefits of Acid Suppression

The main benefit of Prazol therapy is the consistent control of gastric pH levels. By maintaining a less acidic environment in the stomach, the medication provides:

  • Symptom Relief: Significant reduction in the frequency and severity of burning sensations in the chest and throat.
  • Tissue Protection: Prevention of long-term damage to the digestive tract, such as strictures or Barrett's esophagus, which can result from untreated acid reflux.
  • Enhanced Healing: Improved recovery rates for mucosal lesions and ulcers compared to less potent acid-reducing agents.

Regulatory References

  1. European Medicines Agency product information on omeprazole

Eligibility and Restrictions for Use

Official Eligibility and Non-Eligibility for Prazol

This information is based strictly on governmental regulatory documents and defines which populations are approved for Prazol use and which are formally excluded.

Classification Population/Condition
Contraindicated Patients with known hypersensitivity to Prazol, its excipients, or to substituted benzimidazoles (its drug class).
Contraindicated Patients receiving concomitant treatment with specific antivirals (e.g., Rilpivirine or Atazanavir-containing products).
Age-Related Eligibility Use is not established or not approved in children under 5 years of age. Approved for adults and pediatric patients ge 5 years (for limited, approved durations).
Conditional Use Patients with severe hepatic impairment may require dose adjustment due to altered drug clearance.
Physiological Status Use during pregnancy and lactation is generally permitted only if the potential benefit is considered to justify the risks, based on established, low-level exposure data.
Use Restriction Long-term use (e.g., over a year) is subject to official warnings due to documented increased risk of osteoporosis-related fractures and hypomagnesemia, requiring the use of the shortest effective duration.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Prazol is primarily defined by its effects on gastric acidity and the CYP450 enzyme system.

Pharmacokinetic Interactions

Prazol, as a proton pump inhibitor, significantly and persistently raises the stomach's pH. This action interferes with the absorption of certain co-administered medications that require an acidic environment to dissolve and be absorbed efficiently. Drug classes affected include specific antifungals (e.g., ketoconazole) and certain antiretrovirals (e.g., atazanavir).

Additionally, Prazol acts as an inhibitor of the CYP2C19 enzyme. This metabolic effect can alter the plasma concentrations of drugs metabolized by this pathway. Notably, this interaction can diminish the activation and antiplatelet effect of clopidogrel.

Conversely, substances that are strong CYP enzyme inducers, such as rifampin and the herbal supplement St. John's Wort, can significantly lower Prazol’s own plasma levels.

Contraindicated and Clinically Significant Combinations

The co-administration of Prazol with rilpivirine-containing products is specifically contraindicated due to the high risk of severely reduced plasma concentrations of the antiretroviral, potentially leading to treatment failure. Other clinically significant interactions involve methotrexate, where increased Prazol exposure may require closer monitoring, and warfarin, where the combination necessitates monitoring of INR values. Separating the administration time of Prazol and clopidogrel is not sufficient to prevent the documented interaction.

Mechanism of Action

How Prazol Works

Irreversible Blockade of the Proton Pump

Prazol acts as a prodrug that is selectively absorbed and concentrated within the highly acidic environment of the secretory canaliculi of the gastric parietal cells. The low pH environment chemically activates the compound, enabling it to specifically target the H^+/ K^+-ATPase, commonly known as the Proton Pump. The activated molecule forms a stable, irreversible covalent bond with specific cysteine residues on the enzyme. This binding physically and permanently disables the pump's function.


Sustained Modulation of Gastric Acidity

Inhibition of the Proton Pump, the enzyme responsible for extruding hydrogen ions ( H^+) into the stomach lumen, blocks the final common step in the acid secretion pathway. This action results in a sustained suppression of hydrogen ion concentration within the digestive fluids. The resulting physiological consequence is a significant and long-lasting shift in gastric pH, which modulates the chemical reactivity of the stomach contents and impacts the interaction with the exposed gastrointestinal mucosa.

Dosage and Administration Information

How Prazol is Used: Administration Guidelines

This section outlines the standard administration of Prazol (Lansoprazole), detailing the instructions for its proper use.


Administration Protocol

Feature Guideline
Route of Administration Primarily Oral (capsules, ODTs, suspension). Approved alternatives include Nasogastric (NG) Tube and, for specific forms, Intravenous (IV) use.
Timing in Relation to Meals Doses must be taken before eating to ensure adequate absorption, typically recommended 30 minutes prior to a meal.
Handling Restriction Delayed-release capsules and tablets must not be crushed or chewed to preserve the enteric coating, which protects the active ingredient from stomach acid.

Standard Dosing and Duration Patterns

Standard Dosing: Most regimens use 15 mg or 30 mg once daily. Certain regimens, such as those for H. pylori eradication, mandate a 30 mg twice daily schedule. The initial dose for Pathological Hypersecretory Conditions (Zollinger-Ellison Syndrome) may start at 60 mg once daily and be adjusted, potentially requiring up to 180 mg total daily in divided doses.

Course Duration: Treatment courses for acute conditions like erosive esophagitis and ulcers typically last four to eight weeks. Maintenance therapy for preventing relapse may follow a long-term pattern at a lower daily dose.

Population and Procedural Notes

Hepatic Adjustment: A dose reduction is advised for patients with severe hepatic impairment as the medicine is metabolized by the liver. No routine dose adjustment is specified for older adults or those with renal impairment.

Missed Dose: If a dose is missed, it should be taken when remembered, unless it is close to the time for the next scheduled dose, in which case the missed dose must be skipped. Patients must not take two doses at once.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Prazol


Research Base for Ulcer Resolution and Maintenance

Research exploring the use of Prazol for ulcers primarily includes short-term randomized controlled trials (RCTs) and subsequent meta-analyses focused on adults with endoscopically confirmed ulcers. Studies were used in research exploring how symptoms change over time and measured the rates of endoscopic resolution of both duodenal and benign gastric ulcers. Observations regarding the achievement of study endpoints (such as ulcer closure) were reported, along with patterns in patient-reported discomfort. Studies also evaluated whether using the compound over periods of up to a year was associated with maintaining the status of the ulcer. Comparative evidence regarding the compound’s role relative to all other similar medications in long-term maintenance remains limited and varied.


Research Base for Erosive Esophagitis and Reflux Symptoms

RCTs also evaluated Prazol's application in both the assessment of tissue repair (erosive esophagitis) and the evaluation of symptomatic heartburn and regurgitation related to gastroesophageal reflux disease (GERD). For esophagitis, studies monitored physiological changes like the percentage of time the gastric pH was above a certain level, alongside endoscopic healing rates. Research was conducted in subjects experiencing episodic or acute changes in reflux symptoms. The scientific literature often notes a lack of direct, head-to-head comparative evidence against all similar medications specifically for symptom relief in GERD.


Research Gaps and Areas of Uncertainty

Research so far indicates that certain areas have limited information for long-term outcomes that extend beyond one year of use, which is a common research limitation. Furthermore, data for rare conditions like Zollinger-Ellison Syndrome relies on small patient cohorts, and comparative evidence is lacking in the form of direct head-to-head trials against all other similar medications for certain common indications. Studies involving children and adolescents also examined the compound, but the sample sizes of these pediatric studies were often modest.

Key Studies & References Losec (Omeprazole) - Article 30 referrals - Annex III (European Medicines Agency document defining PPI indications)

Frequently Asked Questions (FAQ)

Common questions about Prazol (FAQ)


Q: How quickly should I expect to feel an effect after starting Prazol?

A: Regulatory documents indicate that the medicine is absorbed relatively quickly after dosing, and the compound reaches its highest concentration in the body in less than two hours. Although the medicine has a short half-life, its acid-suppressing effect is sustained and intended to last for approximately 24 hours. Achievement of the full intended therapeutic effect may require more than one dose.

Q: Do I need to take Prazol for a long time?

A: Treatment for acute conditions, such as ulcers or severe inflammation, is typically short-term, often lasting for only a few weeks. Official warnings state that long-term use, defined as use exceeding one year, is associated with documented risks, including a higher risk of bone fracture and low magnesium levels, and is officially recommended to be reviewed by a healthcare provider.

Q: What happens if I stop taking Prazol suddenly?

A: If the medicine is stopped, particularly after extended use, some regulatory guidance notes that it may lead to a temporary increase in acid production, a condition sometimes called rebound acid hypersecretion. This temporary surge in acid could cause original symptoms to return. Any changes to the dose schedule or plan for stopping should be made in consultation with a healthcare provider.

Q: Can Prazol cause stomach problems or pain?

A: Official adverse reaction reports confirm that abdominal pain is a commonly reported side effect. Additionally, long-term use (e.g., over one year) has been associated with the development of Fundic Gland Polyps, which are typically benign growths in the stomach lining.

Q: Can Prazol make you tired or dizzy?

A: Yes, regulatory documentation classifies both Dizziness and Fatigue (tiredness) as common side effects of Prazol. Furthermore, one of the risks of long-term use is low magnesium levels, which can manifest with symptoms such as tiredness or dizziness.

Q: Does Prazol cause weight changes?

A: Official regulatory lists of common side effects do not typically feature significant weight changes. However, post-market data has included reports of both weight gain and weight loss associated with long-term use in some patient populations.

Q: Can Prazol affect my sleep?

A: Official product information notes that Insomnia (difficulty sleeping) is documented as an uncommon adverse reaction. This means it has been observed in a small percentage of patients taking the medicine.

Q: Is it better to take Prazol in the morning or at night?

A: Regulatory guidance focuses on ensuring the medicine is taken before eating (typically 30 minutes prior to a meal) for proper absorption. Regulatory guidance indicates the medicine is effective at inhibiting both daytime and nocturnal acid secretion. While the specific time of day is generally not mandated, the timing is a consideration for the overall treatment plan.

Q: Why do some people say Prazol is hard to stop taking?

A: The perception that the medicine is difficult to stop is likely related to the phenomenon of rebound acid hypersecretion. This temporary surge in acid when stopping the drug can cause symptoms to return, leading some to mistakenly believe the original condition has worsened or that they are dependent on the medicine.

Q: Is there a link between Prazol and bone health issues?

A: Official safety warnings indicate a link between the long-term use of Prazol (usually over one year) and a potential increase in the risk of osteoporosis-related fractures. These fractures have been reported in the hip, wrist, or spine.

Q: Is Prazol used for acid reflux only?

A: No, Prazol is officially approved for managing several conditions related to excessive stomach acid. These include the healing and maintenance of ulcers, treatment of erosive esophagitis (severe damage to the esophagus), and the treatment of rare conditions like Zollinger-Ellison Syndrome.

Q: Can Prazol affect mental clarity or mood?

A: Official documentation lists Depression as an uncommon adverse reaction associated with Prazol. Additionally, severe low magnesium levels, a documented risk of long-term use, have been associated with central nervous system symptoms like confusion or delirium.

Q: How is the safety of Prazol monitored after it is released to the public?

A: Regulatory agencies require manufacturers to conduct continuous post-market surveillance, also known as pharmacovigilance. This is a mandatory process required by regulatory bodies to collect, analyze, and interpret information about the drug's safety profile after it has been released to the public.

Q: Is Prazol available without a prescription in some countries?

A: While the full-strength version of the active ingredient (Lansoprazole) is a prescription-only medicine in many places, low-dose versions have been approved by regulatory bodies for over-the-counter (OTC) use. These lower-dose versions are intended for the short-term treatment of frequent heartburn in certain regions, such as the US and Australia.

Q: What should I do if the medicine doesn't seem to be working?

A: Official warnings state that a response to treatment does not necessarily rule out the presence of a gastric malignancy or other serious underlying disease. If symptoms persist, change, or worsen, a consultation with a healthcare provider may be required for further evaluation and reassessment of the condition.

Q: Are there any specific lifestyle changes recommended alongside Prazol?

A: Healthcare information often suggests that non-drug measures can help manage acid-related symptoms. These general suggestions may include keeping a healthy weight, avoiding large or late meals, and limiting consumption of specific triggers such as spicy or fatty foods, alcohol, and coffee.

How should Prazol be stored and disposed of?

Official Regulatory Storage Requirements

Requirement Standard Condition
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Keep the medicine in its original, tightly closed container. Protect from moisture and light.
Handling Notes Do not freeze the medicine. Keep Prazol out of the sight and reach of children in a secure location.

Stability and Disposal Rules

Regulatory documentation establishes these conditions to ensure the product remains stable until its expiration date. If Prazol is supplied in a multi-dose container, the stability period for use may be limited after the container is first opened.

To dispose of unused or expired Prazol, follow official guidance by utilizing a medicine take-back program. If a program is unavailable, secure the medicine in a sealed container mixed with an undesirable substance before discarding it in the household trash. It is strictly prohibited to flush Prazol down the toilet or pour it down any drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prazol found in:

A-Z Index: